Company Filing History:
Years Active: 1999-2003
Title: The Innovations of Theodore Smith
Introduction
Theodore Smith is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of gene therapy, particularly in the treatment of hemophilia. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Smith's latest patents include innovative adenoviral vectors designed for enhanced gene expression. One of his patents describes an adenoviral vector that includes at least one DNA sequence encoding a clotting factor, such as Factor VIII or Factor IX. These vectors can be administered to a host in an effective amount to treat hemophilia. The vectors are engineered to infect hepatocytes efficiently, allowing for the expression of the clotting factor DNA sequence. Another patent focuses on adenoviral vectors specifically for the treatment of hemophilia, reiterating the importance of these vectors in gene therapy.
Career Highlights
Throughout his career, Theodore Smith has worked with prominent companies in the biotechnology sector, including Genetic Therapy, Inc. and Genetic Therapy, Inc. His experience in these organizations has contributed to his expertise in developing innovative solutions for genetic disorders.
Collaborations
Some of his notable coworkers include Sheila Connelly and Michael Kaleko. Their collaboration has likely fostered an environment of innovation and creativity in their projects.
Conclusion
Theodore Smith's contributions to gene therapy, particularly through his patents on adenoviral vectors, showcase his commitment to advancing medical science. His work has the potential to significantly improve treatment options for individuals with hemophilia.